Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

Add To Watchlist

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Alison took charge at $6.+ ... now we are at .06 cents

View:

Post by zzstocks70 on Nov 02, 2018 9:22pm

Alison took charge at $6.+ ... now we are at .06 cents

What the hell happened here? Why is there no update from management? Why are you shareholders not freaking out? Demand some changes immediately... obviously this is not working out. Maybe Drake and Ally are sitting back waiting til the money runs out and scoop it all up . Shareholders need to revolt somewhat... demand answers and some changes.

197